Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 7

Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial

Total article views   HTML views PDF downloads Totals
18,191 Dovepress* 14,981+ 3,693 18,674
PubMed Central* 3,210 1,789 4,999
Totals 18,191 5,482 23,673
*Since 31 July 2012
+Since July 2016

View citations on PubMed Central and Google Scholar